R

RLMD

RLMD

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
17%Bearish
Buy/Sell Ratio100% buys
BearishBullish
RLMD Live QuoteReal-time
$2.62
$0.67(-20.36%)1M
Day Range$2.60 – $3.13
Open$3.07
Previous Close$3.11
Volume2.25M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$318.48M
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-0.73
Price to Book1.7
Dividend Yield0.65%
Beta (Volatility)0.57
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $2.62 (0%)
Low: $2.83High: $8.00
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$10.75-92.8% upside

Insider Buys

1

$1.67M

Insider Sales

0

$0

Total Volume

$1.67M

6 transactions

Net Activity

+$1.67M

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
75CONFIDENCE

Sentiment Rating

Moderate Accumulation

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
  • •High accumulation: total purchase value exceeds $1M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

P - Purchase Insiders

1 buys5 sells

$978.35B total

Trading History
RLMD insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 9, 2026

2 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.00M$200000.00$200.00B

Sep 9, 2026

2 months ago

Multiple Insiders

2 Insiders

Insider
Buy400.0K$4.18$1.67M

Dec 15, 2025

11 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.30M$27500.00$35.75B

Nov 5, 2025

12 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell788.3K$500000.00$394.17B

Aug 26, 2025

15 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.00M$265976.00$265.98B

May 16, 2025

18 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell412.3K$200000.00$82.46B
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
RLMD Buy Conviction100%
Industry Rank#0 of 569
Volume Contribution0.0%
Total Industry Activity$16.52B

RLMD has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for RLMD

Over the last 90 days, corporate insiders at RLMD (RLMD) engaged in a total of 6 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 0 were sales. The total volume of insider trading reached $1.67M.

The net insider activity for RLMD shows a net buying bias of $1.67M. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 788.3K shares valued at $394.17B on Nov 5, 2025.

Live Market News & Developments
Aggregated real-time headlines for RLMD (RLMD)
6 updates

$RLMD stock is down 17% today. Here's what we see in our data.

Quiver Quantitative4d ago

Here's Why Relmada Therapeutics (RLMD) Is a Great 'Buy the Bottom' Stock Now

Yahoo Finance87d ago

RLMD - Relmada Therapeutics Inc Stock Price and Quote

Finviz176d ago

RLMD Forecast — Price Target — Prediction for 2027

TradingView147d ago

Relmada's planned Nov. 12 webcast will cover quarterly results and business progress.

Stock Titan17d ago

Down 29.6% in 4 Weeks, Here's Why Relmada Therapeutics (RLMD) Looks Ripe for a Turnaround

Yahoo Finance101d ago

FAQs About RLMD Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for RLMD.

Based on SEC Form 4 disclosures, the Insider Confidence Score for RLMD is currently 75/100, which reflects a moderate accumulation bias. This calculation accounts for a total of 1 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for RLMD is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.